2019 Blood Typing, Grouping and Infectious Disease NAT Screening: Supplier Shares and Strategic Assessments of Leading Market Players

This new 225-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking Technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.



1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
-Pathogenesis & Pathology
-Overview of Course of HIV Infection
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
-Clinical Findings
- Plasma Viral Load
- Pediactric AIDS
-Neurologic Disease
-Opportunistic Infections
-Protozoa
-Fungi
-Bacteria


- Viruses
- Cancer
- Immunity
- Laboratory Diagnosis
-Virus Isolation
-Serology
-Detection of Viral Nucleic Acid or Antigens
- Epidemiology
-Worldwide Spread of AIDS
-United States
-Routes of Transmission
- Prevention, Treatment, And Control
-Antiviral Drugs
-Vaccines Against HIV
- Transmission of HIV in Blood Products
- HIV Transmission in Transplant and
Artificial Insemination Recipients
- Diagnostic Tests
- Enzyme Immunoassay Interpretation
- Specificity, Sensitivity, and Predictive
Value of Enzyme Immunoassay
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assay (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- DNA Probes
- Overview
- Quantitative Polymerase Chain Reaction
- In Situ PCR
- Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis
- Hepatitis A
- Hepatitis B
-Structure and Composition
-Replication of Hepatitis B Virus


- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis Virus Infections In Humans
-Pathology
- Clinical Findings
- Laboratory Features
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D
-Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D (Delta Agent)
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
-Erythema Infectiosum Slapped (cheek)
-Adult Polyarthropathy


-Transient Aplastic Crisis
-Transient Pancytopenia
-Red Cell Aplasia in the Immunocompromised
-Perinatal Infections
- Diagnosis
- Treatment
g. Creutzfeldt-Jakobs Disease
- Background
- Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
-Bayer
-Disease Sciences/BioTec Global
-Imperial College School of Medicine
-Ortho-Clinical Diagnostics
-Pall
-ProMetic Life Sciences
-Proteome Sciences/Idexx
-Q-One Biotech
-Serono
-U.S. Agricultural Research Service
- Drugs
- Vaccines
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin

- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Immucor
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Roche
- Siemens
- Tecan
- Thermo Fisher


List Of Tables



Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or Marketing
HLA Typing Tests
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
Syphilis Tests

2020 Germany Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key German market trends; reviews

USD 3500 View Report

2020 France Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews

USD 3500 View Report

2020 US Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2019-2023: Supplier Shares, Volume and Sales Forecasts by Test and Market Segment, Competitive Strategies, Emerging Technologies, Latest Instrumentation

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years,

USD 4500 View Report

2020 UK Molecular Blood Typing, Grouping and Infectious Disease NAT Market, 2019-2023: Supplier Shares, Volume and Sales Forecasts by Test and Market Segment, Competitive Strategies, Emerging Technologies, Latest Instrumentation

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years,

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available